EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma
about
NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligandsLoss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivationNHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membraneThe scaffolding protein EBP50 regulates microvillar assembly in a phosphorylation-dependent mannerPodocalyxin EBP50 ezrin molecular complex enhances the metastatic potential of renal cell carcinoma through recruiting Rac1 guanine nucleotide exchange factor ARHGEF7Breast cancer-derived K172N, D301V mutations abolish Na+/H+ exchanger regulatory factor 1 inhibition of platelet-derived growth factor receptor signalingRegulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factorsPTEN, NHERF1 and PHLPP form a tumor suppressor network that is disabled in glioblastomaThe nuclear receptor hepatocyte nuclear factor 4alpha acts as a morphogen to induce the formation of microvilliEzrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epitheliaNHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility.The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymomaGene profile analysis of osteoblast genes differentially regulated by histone deacetylase inhibitors.NHERF-1: modulator of glioblastoma cell migration and invasionReduced EBP50 expression levels are correlated with unfavorable clinicopathological features of extrahepatic bile duct carcinoma and promote the proliferation and migration of QBC939 cells.Engineering peptide inhibitors to overcome PDZ binding promiscuity.Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma.EBP50 regulates the apoptosis of pancreatic cancer cells by decreasing the expression levels of Bcl-2.NHERF1/EBP50 in Breast Cancer: Clinical PerspectivesPTEN Tumor Suppressor Network in PI3K-Akt Pathway ControlCell cycle dependent association of EBP50 with protein phosphatase 2A in endothelial cellsNHERF1/EBP50 is a new marker in colorectal cancer.The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1).Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1)Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 ProteinsAberrant nuclear localization of EBP50 promotes colorectal carcinogenesis in xenotransplanted mice by modulating TCF-1 and β-catenin interactions.Prognostic significance of peroxiredoxin 1 and ezrin-radixin-moesin-binding phosphoprotein 50 in cholangiocarcinoma.The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.NHERF1/EBP50 controls lactation by establishing basal membrane polarity complexes with prolactin receptor.EBP50 inhibits EGF-induced breast cancer cell proliferation by blocking EGFR phosphorylation.A novel splicing mutation in the SLC9A3R1 gene in tumors from ovarian cancer patients.EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration.Na/H exchange regulatory factor 1, a novel AKT-associating protein, regulates extracellular signal-regulated kinase signaling through a B-Raf-mediated pathway.Temporal and spatial regulation of ezrin-radixin-moesin-binding phosphoprotein-50-kDa (EBP50) during embryo implantation in mouse uterus.SLC9A3R1 stimulates autophagy via BECN1 stabilization in breast cancer cellsRas-activated RSK1 phosphorylates EBP50 to regulate its nuclear localization and promote cell proliferation.In MMTV-Her-2/neu transgenic mammary tumors the absence of caveolin-1-/- alters PTEN and NHERF1 but not β-catenin expression.Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferationNHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
P2860
Q24294023-37376248-313D-4390-88A0-963B671B592AQ24297357-E43A20B3-B891-464A-B20D-1623B1C34226Q24298305-0F506CC6-D02F-4F81-8E17-554D637CF206Q24302333-EB2D31C8-CC4D-4B19-9B96-DE2D224F2DA2Q24306767-78D9A110-2465-4704-9A1C-0D0D4B08691CQ24323184-BD86AD7C-C34A-48F0-B735-B283403C5BE8Q26863645-85D814F0-D38D-463B-B1C8-CA398BF60BA0Q28115966-0213D6AE-2E70-4B21-87C9-1271FCF061E7Q28576784-C02C1322-9389-4DA4-AC60-6C49C618B8C6Q28588034-2D92D9C7-7556-4E7B-BA76-0A6751F5B884Q30479197-3E166506-839B-466C-94EC-F84D0F91092EQ30479321-979F29C4-9749-469E-8514-9DC4BF17922CQ30625458-3FF72EFC-3988-4455-88BA-189D6BD66617Q33302058-8FEC858E-D2B7-4E78-A9F2-5BDE0A1E36C0Q33420852-88A2CE20-C3A6-40A1-BAAE-C2D950C018CCQ33597837-3EC36D51-50DF-4FD5-82E1-D03D0FFFB5DCQ33755113-1CF0FB2D-53B2-4FA4-8493-DE9A76EF3E5BQ33932203-078DA1A5-4055-4D7F-9B6F-7505D934D759Q33962655-559D2277-E175-40AF-BD67-924A197A7302Q34096013-986778AC-5B4B-453B-8F49-6E76A8ACCACEQ34202681-271A141E-F55D-4986-9E92-D0BE10EDE370Q34241905-EC79F93A-B869-44B4-B8BF-B39F2EB62E8BQ34411711-D0FC0E32-E5A4-4724-9CB3-E7B46B13B4B7Q35621438-9154F24E-DC2A-4783-94E5-530BAA9DE668Q35633702-EFB30DD0-7141-4D08-9160-B6F6A4DD3DD5Q35795744-B6B32E2F-3AA1-403A-93C6-55888C7F4061Q35913641-03449D53-F969-4DF1-8421-CF4EA4FE38B4Q36066974-619B500F-BC3F-421F-A6F3-8BE860E696D5Q36214152-7CAF1158-1F6B-4960-BE7F-01A5E4CABB1CQ36288731-F43A70AC-B9DB-4938-8E9C-954EC41F0041Q36319689-AAA4AC23-AF3A-45F7-A7DE-17D6D98EC828Q36334877-61CF955D-EEFB-40AD-8C18-D77817AB9244Q36392890-E7DF98B1-D0E9-4B43-8DB8-0F71BB9F9729Q36536571-B5AEA8A7-445B-42C8-B6B6-58651DCFBAE5Q36538416-15084D41-7B4B-476C-900D-3F792E3F9DE9Q36808215-7D40EEF1-7561-4915-A734-EE355E127CF2Q36962945-30C6CDFD-B241-488C-9512-BC3012C80203Q37099496-4FA02412-2779-465C-9F66-01D5E386ADA6Q37150777-8279D079-8A16-401E-8BE9-43DA6273586CQ37246058-44AFDBFE-795C-40DC-924F-5E6232AA6CAC
P2860
EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@ast
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@en
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@nl
type
label
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@ast
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@en
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@nl
prefLabel
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@ast
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@en
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@nl
P2093
P3181
P356
P1433
P1476
EBP50, a beta-catenin-associat ...... ed in hepatocellular carcinoma
@en
P2093
Akiko Kokubu
Makoto Chuma
Michiie Sakamoto
Setsuo Hirohashi
Tatsuhiro Shibata
P304
P3181
P356
10.1053/JHEP.2003.50270
P407
P577
2003-07-01T00:00:00Z